| 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0,0 € | 0,0 € | — | 0,0 € | -100.0% | 4,3 M € | 0,0 € | ||||||||
| Gross margin | 729,7 k € | — | — | — | — | — | — | — | — | |||||||||
| EBITDA | 112,1 k € | -80.4% | 572,3 k € | -7.4% | 618,2 k € | +141.1% | 256,4 k € | +13.5% | 225,9 k € | +10.8% | 204,0 k € | +4.9% | 194,4 k € | +63.6% | 118,8 k € | +2690.6% | -4,6 k € | |
| Operating profit | -271,7 k € | -303.7% | 133,4 k € | -12.7% | 152,8 k € | +17584.1% | 864,0 € | -98.6% | 59,7 k € | +3.6% | 57,6 k € | +1.4% | 56,9 k € | -12.3% | 64,9 k € | +603.8% | -12,9 k € | |
| Profit/loss | -298,3 k € | -365.3% | 112,4 k € | -47.0% | 212,2 k € | +241.6% | 62,1 k € | +15.6% | 53,7 k € | +17.6% | 45,7 k € | -2.5% | 46,8 k € | -11.6% | 53,0 k € | +261.9% | 14,6 k € | |
| Equity | 3,8 M € | -7.3% | 4,1 M € | +2.8% | 4,0 M € | +75.2% | 2,3 M € | +2.8% | 2,2 M € | +2.5% | 2,2 M € | +2.2% | 2,1 M € | +2.3% | 2,1 M € | +2.4% | 2,0 M € | |
| Total assets | 4,9 M € | -4.5% | 5,2 M € | +10.5% | 4,7 M € | -1.6% | 4,7 M € | +61.1% | 2,9 M € | +6.5% | 2,8 M € | +1.0% | 2,7 M € | -1.1% | 2,8 M € | -20.9% | 3,5 M € | |
| Cash | 33,9 k € | +2307.8% | 1,4 k € | -68.9% | 4,5 k € | -74.3% | 17,6 k € | -91.2% | 199,3 k € | +720.8% | 24,3 k € | -33.3% | 36,4 k € | +41.1% | 25,8 k € | +69.8% | 15,2 k € | |
| Debts | 1,1 M € | +14.8% | 948,6 k € | +40.6% | 674,7 k € | -72.6% | 2,5 M € | +238.4% | 728,1 k € | +21.1% | 601,4 k € | -2.9% | 619,4 k € | -11.0% | 696,2 k € | -52.7% | 1,5 M € | |
| Staff | 7,4 | 18,7 | 22,9 | 7,8 | 4,4 | 3,8 | 3,4 | 3,1 | 2,9 | |||||||||
Public limited company · Antwerpen · incorporated on 18/09/2007 · 7,4 ETP
Company — Opening of bankruptcy.
Public limited company loss-making in the latest fiscal year. Cash position rising (+2307.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
GALILEI BIOTECHNOLOGY CENTER is a Public limited company incorporated in 2007. Its main activity is: Rental and operating of own or leased real estate. Its registered office is in Antwerpen. It employs on average 7,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette